Package 61245-616-13

{"route": ["ORAL"], "spl_id": "3e5d77e9-913f-41d7-e063-6294a90a365e", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["ba9ba697-d3df-49d7-e053-2a95a90af406"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Direct Safety"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "250 PACKET in 1 BOX (61245-616-13)  / 2 TABLET, FILM COATED in 1 PACKET", "package_ndc": "61245-616-13", "marketing_start_date": "20210215"}], "brand_name": "Direct Safety Aspirin", "product_id": "61245-616_3e5d77e9-913f-41d7-e063-6294a90a365e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "61245-616", "generic_name": "Aspirin", "labeler_name": "Direct Safety", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Direct Safety Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210215", "listing_expiration_date": "20261231"}